Literature DB >> 26407972

Pseudomonas aeruginosa: breaking down barriers.

Bryan J Berube1, Stephanie M Rangel1, Alan R Hauser2,3.   

Abstract

Many bacterial pathogens have evolved ingenious ways to escape from the lung during pneumonia to cause bacteremia. Unfortunately, the clinical consequences of this spread to the bloodstream are frequently dire. It is therefore important to understand the molecular mechanisms used by pathogens to breach the lung barrier. We have recently shown that Pseudomonas aeruginosa, one of the leading causes of hospital-acquired pneumonia, utilizes the type III secretion system effector ExoS to intoxicate pulmonary epithelial cells. Injection of these cells leads to localized disruption of the pulmonary-vascular barrier and dissemination of P. aeruginosa to the bloodstream. We put these data in the context of previous studies to provide a holistic model of P. aeruginosa dissemination from the lung. Finally, we compare P. aeruginosa dissemination to that of other bacteria to highlight the complexity of bacterial pneumonia. Although respiratory pathogens use distinct and intricate strategies to escape from the lungs, a thorough understanding of these processes can lay the foundation for new therapeutic approaches for bacterial pneumonia.

Entities:  

Keywords:  Bacterial dissemination; ExoS; Pneumonia; Pseudomonas aeruginosa; Type III secretion

Mesh:

Substances:

Year:  2015        PMID: 26407972      PMCID: PMC4724561          DOI: 10.1007/s00294-015-0522-x

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  53 in total

1.  Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.

Authors:  Jacobien J Hoogerwerf; Gerritje J W van der Windt; Dana C Blok; Arie J Hoogendijk; Alex F De Vos; Cornelis van 't Veer; Sandrine Florquin; Koichi S Kobayashi; Richard A Flavell; Tom van der Poll
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

2.  The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function.

Authors:  Grace Soong; Dane Parker; Mariah Magargee; Alice S Prince
Journal:  J Bacteriol       Date:  2007-12-28       Impact factor: 3.490

3.  CCAAT-enhancer binding protein delta (C/EBPδ) protects against Klebsiella pneumoniae-induced pulmonary infection: potential role for macrophage migration.

Authors:  JanWillem Duitman; Arie J Hoogendijk; Angelique P Groot; Roberta R Ruela de Sousa; Tom van der Poll; Sandrine Florquin; C Arnold Spek
Journal:  J Infect Dis       Date:  2012-11-12       Impact factor: 5.226

4.  CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner.

Authors:  Janwillem Duitman; Marcel Schouten; Angelique P Groot; Keren S Borensztajn; Joost B Daalhuisen; Sandrine Florquin; Tom van der Poll; C Arnold Spek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

5.  Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.

Authors:  Ali A El-Solh; Angela Hattemer; Alan R Hauser; Ahmad Alhajhusain; Hardik Vora
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

6.  Streptococcus pneumoniae induces exocytosis of Weibel-Palade bodies in pulmonary endothelial cells.

Authors:  Melanie Lüttge; Marcus Fulde; Susanne R Talay; Andreas Nerlich; Manfred Rohde; Klaus T Preissner; Sven Hammerschmidt; Michael Steinert; Tim J Mitchell; Gursharan S Chhatwal; Simone Bergmann
Journal:  Cell Microbiol       Date:  2011-11-03       Impact factor: 3.715

7.  Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-1-/- mice.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Balamayooran Theivanthiran; Shanshan Cai; Pal Pacher; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-11-05       Impact factor: 5.422

8.  Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis.

Authors:  Ahmed Achouiti; Thomas Vogl; Constantin F Urban; Marc Röhm; Tijmen J Hommes; Marieke A D van Zoelen; Sandrine Florquin; Johannes Roth; Cornelis van 't Veer; Alex F de Vos; Tom van der Poll
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

9.  Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection.

Authors:  Naoko Inoshima; Yang Wang; Juliane Bubeck Wardenburg
Journal:  J Invest Dermatol       Date:  2012-03-01       Impact factor: 8.551

10.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

View more
  19 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.

Authors:  Bryan J Berube; Katherine R Murphy; Matthew C Torhan; Nicholas O Bowlin; John D Williams; Terry L Bowlin; Donald T Moir; Alan R Hauser
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  The extreme C terminus of the Pseudomonas aeruginosa effector ExoY is crucial for binding to its eukaryotic activator, F-actin.

Authors:  Alexander Belyy; Ignacio Santecchia; Louis Renault; Blandine Bourigault; Daniel Ladant; Undine Mechold
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

Review 4.  Recent advances in understanding Pseudomonas aeruginosa as a pathogen.

Authors:  Jens Klockgether; Burkhard Tümmler
Journal:  F1000Res       Date:  2017-07-28

5.  In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics.

Authors:  Xiaolei Pan; Yuanyuan Dong; Zheng Fan; Chang Liu; Bin Xia; Jing Shi; Fang Bai; Yongxin Jin; Zhihui Cheng; Shouguang Jin; Weihui Wu
Journal:  Front Cell Infect Microbiol       Date:  2017-03-14       Impact factor: 5.293

6.  Pseudomonas aeruginosa infection increases the readmission rate of COPD patients.

Authors:  Juwhan Choi; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang; Kyung Hoon Min
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-02

7.  Bronchial Epithelial Tet2 Maintains Epithelial Integrity during Acute Pseudomonas aeruginosa Pneumonia.

Authors:  Wanhai Qin; Xanthe Brands; Cornelis Van't Veer; Alex F de Vos; Brendon P Scicluna; Tom van der Poll
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 8.  Pathogenesis of Gram-Negative Bacteremia.

Authors:  Caitlyn L Holmes; Mark T Anderson; Harry L T Mobley; Michael A Bachman
Journal:  Clin Microbiol Rev       Date:  2021-03-10       Impact factor: 26.132

9.  The Efficacy of Phage Therapy in a Murine Model of Pseudomonas aeruginosa Pneumonia and Sepsis.

Authors:  Xu Yang; Anwarul Haque; Shigenobu Matsuzaki; Tetsuya Matsumoto; Shigeki Nakamura
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.